AbbVie
ABBV
#29
Rank
C$696.38 B
Marketcap
C$394.08
Share price
1.49%
Change (1 day)
22.08%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : C$200.98 Billion

According to AbbVie's latest financial reports the company's total liabilities are C$200.98 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$187.87 B-0.66%
2024-12-31C$189.12 B14.7%
2023-12-31C$164.88 B-0.01%
2022-12-31C$164.89 B-1.3%
2021-12-31C$167.07 B-4.68%
2020-12-31C$175.28 B37.95%
2019-12-31C$127.06 B37.58%
2018-12-31C$92.35 B11.83%
2017-12-31C$82.58 B-0.01%
2016-12-31C$82.59 B21.26%
2015-12-31C$68.11 B127.77%
2014-12-31C$29.90 B13.72%
2013-12-31C$26.29 B11.85%
2012-12-31C$23.51 B204.59%
2011-12-31C$7.71 B42.18%
2010-12-31C$5.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$164.83 B-17.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$154.51 B-23.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$119.66 B-40.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$18.87 B-90.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$53.62 B-73.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$93.10 B-53.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$93.31 B-53.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$84.16 B-58.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$2.37 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA